Beam Therapeutics Inc.
BEAM· Nasdaq
Beam Therapeutics Inc.
- Last sale
- Oct 2, 2026 · +0.43%
- Market cap
- $2.53B
- 103.29M shares
- Filings
- 509
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $139,743,000 | reported | |
| FY 2024 | 2024-12-31 | $63,518,000 | reported | |
| FY 2023 | 2023-12-31 | $377,709,000 | reported | |
| FY 2022 | 2022-12-31 | $60,920,000 | reported | |
| FY 2021 | 2021-12-31 | $51,844,000 | reported | |
| FY 2020 | 2020-12-31 | $24,000 | reported | |
| FY 2019 | 2019-12-31 | $18,000 | reported |
Beam Therapeutics Inc. · CIK 1745999 · Engraved from SEC EDGAR
